MRVL vs MS: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and Morgan Stanley โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-17.
Marvell Technology, Inc. ยท Technology
$310.58
-18.5% upside to fair value
Grade D
VS
Morgan Stanley ยท Financial Services
$218.37
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
MS has more upside to fair value (+45.0%). MS trades at a lower forward P/E (23.6x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric MRVL MS
Current Price $310.58 $218.37
Fair Value Estimate $253.23 $316.64
Upside to Fair Value -18.5% +45.0%
Market Cap $271.7B $344.4B
Forward P/E 105.7x 23.6x
EV / EBITDA 59.1x 9.8x
Price / Sales 31.2x 2.7x
Price / FCF 163.2x -327.4x
Revenue Growth YoY +27.6% +22.4%
Gross Margin 50.6% 56.6%
Operating Margin 16.2% 28.4%
Return on Equity 16.8% 23.4%
Dividend Yield 0% 0%
FCF Yield 0.61% โ€”
Analyst Consensus Strong Buy Hold
Investment Thesis
MRVL โ€” Marvell Technology, Inc.
Marvell Technology, Inc. designs and supplies semiconductor solutions primarily focused on data infrastructure markets including cloud, AI, carrier 5G, and custom silicon. The company benefits from a narrow but widening moat driven by strong IP and hyperscaler relationships, led by an experienced CEO with a track record of transformational M&A. Despite strong revenue growth of 42% year-over-year โ€ฆ
MS โ€” Morgan Stanley
Morgan Stanley is a leading global financial services firm specializing in capital markets, wealth management, and investment banking. The company demonstrates high business quality with a strong return on equity of 23.4% and robust revenue growth of 22.4% in the most recent quarter, alongside impressive earnings growth of 57.7% in the same period. Its gross margin of 56.6% and net margin of 20.2โ€ฆ
Accumulation Zones
Metric MRVL MS
Zone Low $189.92 $237.48
Zone High $215.25 $269.14
In Buy Zone? No Yes
โ† MRVL Research    MS Research โ†’    All Research